Your search returned 4 results.

Results
	1.	Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin. [electronic resource] by Li, Yizhu Köpper, Frederik Dobbelstein, Matthias Producer: 20190805 In: Cancer letters vol. 428 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells. [electronic resource] by Köpper, Frederik Binkowski, Anna Maria Bierwirth, Cathrin Dobbelstein, Matthias Producer: 20141022 In: Cell cycle (Georgetown, Tex.) vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Extrinsic and intrinsic regulation of DOR/TP53INP2 expression in mice: effects of dietary fat content, tissue type and sex in adipose and muscle tissues. [electronic resource] by Fromm-Dornieden, Carolin Lytovchenko, Oleksandr von der Heyde, Silvia Behnke, Nina Hogl, Sebastian Berghoff, Janina Köpper, Frederik Opitz, Lennart Renne, Ulla Hoeflich, Andreas Beissbarth, Tim Brenig, Bertram Baumgartner, Bernhard G Producer: 20121119 In: Nutrition & metabolism vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity. [electronic resource] by Köpper, Frederik Bierwirth, Cathrin Schön, Margarete Kunze, Meike Elvers, Ingegerd Kranz, Dominique Saini, Priyanka Menon, Manoj B Walter, David Sørensen, Claus Storgaard Gaestel, Matthias Helleday, Thomas Schön, Michael P Dobbelstein, Matthias Producer: 20131209 In: Proceedings of the National Academy of Sciences of the United States of America vol. 110 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)